You are here: Introduction > Presentation
 
        PreviousNext
 
Dopram-V Injection 20 mg/ml Solution for Injection:  Presentation
 
 
Dopram-V Injection 20 mg/ml Solution for Injection
Presentation
Dopram-V Solution for Injection is presented in multi-dose vials containing 20 ml of sterile solution for parenteral and topical sublingual use. Each ml contains Doxapram Hydrochloride 20 mg. It also contains Chlorbutanol 5 mg/ml as an antimicrobial preservative. Dopram-V (doxapram hydrochloride) is a potent respiratory stimulant. It differs from the analeptic agents in having greater specificity of action on the respiratory centre.
Metabolism:
The metabolism of doxapram has been studied in the dog and man. Doxapram is extensively metabolised; the metabolites and unchanged doxapram are excreted in the bile and urine. The pharmacokinetic properties of doxapram can be described by a multi-compartmental model. Due to rapid redistribution the pharmacological effects of an intravenous injection of doxapram are terminated within 15-20 minutes following administration.
           
 
        PreviousNext
  Date updated: 1 July 2008